Recursion Pharmaceuticals, Inc. (RXRX)
3.54
-0.04
(-1.12%)
USD |
NASDAQ |
Feb 13, 14:14
Recursion Pharmaceuticals Free Cash Flow : -450.20M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| XOMA Royalty Corp. | -15.89M |
| Mirum Pharmaceuticals, Inc. | 44.32M |
| Hims & Hers Health, Inc. | 116.09M |
| Plus Therapeutics, Inc. | -15.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -117.36M |
| Cash from Investing (Quarterly) | -2.549M |
| Cash from Financing (Quarterly) | 251.34M |
| Free Cash Flow Per Share (Quarterly) | -0.2631 |
| Free Cash Flow to Equity (Quarterly) | -111.90M |
| Free Cash Flow to Firm (Quarterly) | -116.77M |
| Free Cash Flow Yield | -31.73% |